Xing Z - Search Results

1

Heterologous boosting of recombinant adenoviral prime immunization with a novel vesicular stomatitis virus-vectored tuberculosis vaccine.

Roediger EK, Kugathasan K, Zhang X, Lichty BD, Xing Z. Roediger EK, et al. Among authors: xing z. Mol Ther. 2008 Jun;16(6):1161-9. doi: 10.1038/mt.2008.59. Epub 2008 Mar 25. Mol Ther. 2008. PMID: 18388911 Free PMC article.

2

Enhanced immunogenicity of BCG vaccine by using a viral-based GM-CSF transgene adjuvant formulation.

Wang J, Zganiacz A, Xing Z. Wang J, et al. Among authors: xing z. Vaccine. 2002 Jul 26;20(23-24):2887-98. doi: 10.1016/s0264-410x(02)00241-4. Vaccine. 2002. PMID: 12126899

3

Enhanced HER-2/neu-specific antitumor immunity by cotransduction of mouse dendritic cells with two genes encoding HER-2/neu and alpha tumor necrosis factor.

Chen Z, Huang H, Chang T, Carlsen S, Saxena A, Marr R, Xing Z, Xiang J. Chen Z, et al. Among authors: xing z. Cancer Gene Ther. 2002 Sep;9(9):778-86. doi: 10.1038/sj.cgt.7700498. Cancer Gene Ther. 2002. PMID: 12189528

4

Tuberculosis vaccines: the past, present and future.

Wang J, Xing Z. Wang J, et al. Among authors: xing z. Expert Rev Vaccines. 2002 Oct;1(3):341-54. doi: 10.1586/14760584.1.3.341. Expert Rev Vaccines. 2002. PMID: 12901573 Free article. Review.

5

Single intranasal mucosal Mycobacterium bovis BCG vaccination confers improved protection compared to subcutaneous vaccination against pulmonary tuberculosis.

Chen L, Wang J, Zganiacz A, Xing Z. Chen L, et al. Among authors: xing z. Infect Immun. 2004 Jan;72(1):238-46. doi: 10.1128/IAI.72.1.238-246.2004. Infect Immun. 2004. PMID: 14688101 Free PMC article.

6

Activation of CD8 T cells by mycobacterial vaccination protects against pulmonary tuberculosis in the absence of CD4 T cells.

Wang J, Santosuosso M, Ngai P, Zganiacz A, Xing Z. Wang J, et al. Among authors: xing z. J Immunol. 2004 Oct 1;173(7):4590-7. doi: 10.4049/jimmunol.173.7.4590. J Immunol. 2004. PMID: 15383593

7

Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis.

Wang J, Thorson L, Stokes RW, Santosuosso M, Huygen K, Zganiacz A, Hitt M, Xing Z. Wang J, et al. Among authors: xing z. J Immunol. 2004 Nov 15;173(10):6357-65. doi: 10.4049/jimmunol.173.10.6357. J Immunol. 2004. PMID: 15528375

8

Mechanisms of mucosal and parenteral tuberculosis vaccinations: adenoviral-based mucosal immunization preferentially elicits sustained accumulation of immune protective CD4 and CD8 T cells within the airway lumen.

Santosuosso M, Zhang X, McCormick S, Wang J, Hitt M, Xing Z. Santosuosso M, et al. Among authors: xing z. J Immunol. 2005 Jun 15;174(12):7986-94. doi: 10.4049/jimmunol.174.12.7986. J Immunol. 2005. PMID: 15944305

9

Adenoviral vectors for mucosal vaccination against infectious diseases.

Santosuosso M, McCormick S, Xing Z. Santosuosso M, et al. Among authors: xing z. Viral Immunol. 2005;18(2):283-91. doi: 10.1089/vim.2005.18.283. Viral Immunol. 2005. PMID: 16035940 Review.

10

Recent advances in the development of adenovirus- and poxvirus-vectored tuberculosis vaccines.

Xing Z, Santosuosso M, McCormick S, Yang TC, Millar J, Hitt M, Wan Y, Bramson J, Vordermeier HM. Xing Z, et al. Curr Gene Ther. 2005 Oct;5(5):485-92. doi: 10.2174/156652305774329230. Curr Gene Ther. 2005. PMID: 16250889 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,654 results

Search Page

Filters